Paraneoplastic erythrocytosis associated with an inactivating point mutation of the von Hippel-Lindau gene in a renal cell carcinoma

Blood

Volumn 99, Issue 10, 2002, Pages 3562-3565

  Wiesener, Michael S ^a,b,c   Seyfarth, Melchior ^a,b,c   Warnecke, Christina ^a,b,c   Jürgensen, Jan Steffen ^a,b,c   Rosenberger, Christian ^a,b,c   Morgan, Neil V ^a,b,c   Maher, Eamonn R ^a,b,c   Frei, Ulrich ^a,b,c   Eckardt, Kai Uwe ^a,b,c,d  

^a HUMBOLDT UNIVERSITY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ERYTHROCYTOSIS; GENE; GENE FUNCTION; GENETIC ANALYSIS; HEART INFARCTION; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; PARANEOPLASTIC SYNDROME; POINT MUTATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

EID: 0037092950     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.10.3562     Document Type: Article

References (32)

1. Erythropoietin
2. Oxygen sensing and molecular adaptation to hypoxia
3. 2 homeostasis by hypoxia-inducible factor 1
4. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
5. Von Hippel-Lindau disease
6. The von Hippel-Lindau tumor suppressor protein
7. 2 sensing
8. 2-regulated prolyl hydroxylation
9. Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation
10. Gene expression of erythropoietin in renal cell carcinoma
11. Tumor cells are the site of erythropoietin synthesis in human renal cancers associated with polycythemia
12. New human renal carcinoma cell line established from a patient with erythrocytosis
13. Erythropoietin production in a primary culture of human renal carcinoma cells maintained in nude mice
14. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1α in clear cell renal carcinomas
15. Induction of endothelial PAS domain protein-1 by hypoxia: Characterization and comparison with hypoxia-inducible factor-1α
16. Hypoxia-inducible expression of tumor-associated carbonic anhydrases
17. Up-regulation of hypoxia-inducible factors HIF-1α and HIF-2α under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function
18. Software and database for the analysis of mutations in the VHL gene
19. Structure of the VHL-ElonginC-ElonginB complex: Implications for VHL tumor suppressor function
20. Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein
21. Contrasting effects on HIF-1α regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease
22. Pathogenetic mechanisms of polycythemia vera and congenital polycythemic disorders
23. Renal-cell carcinoma
24. Erythropoietin levels in patients with renal tumors or cysts
25. Prevalence of paraneoplastic erythropoietin production by renal cell carcinomas
26. Erythropoietin in renal cell carcinoma: Evaluation of its usefulness as a tumor marker
27. Colocalization of erythropoietin mRNA and ecto-5'-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin
28. Identification of the renal erythropoietin-producing cells using transgenic mice
29. Production of erythropoietin-like activity by human renal and hepatic carcinomas in cell culture
30. Erythropoietin levels in the course of a patient with erythropoietin-producing renal cell carcinoma and transplantation of this tumor in nude mice
31. Erythropoietin-induced polycythemia in athymic mice following transplantation of a human renal carcinoma cell line
32. Erythropoietin stimulates proliferation of human renal carcinoma cells